NCT06484192
Pain Control After Lumbar Spine Fusion
UNKNOWN
PHASE4Ages 18+InterventionalTreatmentRothman Institute OrthopaedicsInvestigator-initiated
~428 participants
Updated 2024-07-03 on ClinicalTrials.gov
What's tested:Naproxen 500 MgKetorolacOxyCODONE 5 mg Oral TabletMetaxalone 800 MG
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Fusion failure
Measured over 2 years
Conditions
Where it's being run
1 sites across 1 statesPennsylvania1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
≥18 years of age, ≥1-level planned lumbar spinal fusion
Capacity to enroll
English speaking
Exclusion
Chronic kidney disease (preoperative creatinine ≥1.4)
History of gastrointestinal bleed or peptic ulcer disease
History of spinal fusion nonunion
Non-steroidal anti-inflammatory drug allergy
Previously diagnosed coagulopathy
Preoperative thrombocytopenia (platelets \<100,000)
Connective tissue disease
Operative indication due to infection, neoplasm, or trauma
Currently pregnant
What this trial measures
- Fusion failure2 years
Failure of fusion surgery will be measured by the rate of revisions as demonstrated by participant x-rays